This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Merck & Co. Gardasil Sales Lawsuit
Business class action

Merck & Co. Gardasil Sales Lawsuit

Analysis based on 7 articles · First reported Feb 12, 2025 · Last updated Feb 22, 2025

Sentiment
-50
Attention
4
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Merck & Co. and the alleged misleading statements regarding Gardasil sales in China have led to significant drops in Merck & Co.'s stock price. This event highlights the importance of transparent financial reporting for publicly traded companies, especially concerning key product performance in major markets.

Pharmaceuticals Legal Services
Event Summary

Merck & Co. is facing a class action lawsuit, Cronin v. Merck & Co., Inc., filed by Robbins Geller Rudman & Dowd LLP on behalf of investors who purchased Merck & Co. securities between February 3, 2022, and February 3, 2025. The lawsuit alleges that Merck & Co. and its executives made false and misleading statements regarding the projected revenue outlook and anticipated growth of its Gardasil vaccine, particularly in China, while downplaying competition and risks. Disclosures on July 30, 2024, about a significant step down in shipments from its partner Jiang Rensheng in China, and on February 4, 2025, about a 3% decline in Gardasil sales primarily due to lower demand in China, caused Merck & Co.'s stock price to fall by nearly 10% and more than 9% respectively.

Key Actions
100 Robbins Geller Rudman & Dowd LLP filed class action lawsuit Merck & Co.
90 Merck & Co. published Q4 2024 results
80 Merck & Co. revealed step down Jiang Rensheng
Entities Involved
per
Jiang Rensheng
Importance 0.0 Sentiment 0.0
stock
Merck & Co.
Importance 0.0 Sentiment 0.0
priv
Robbins Geller Rudman & Dowd LLP
Importance 0.0 Sentiment 0.0
cnt
China
Importance 0.0 Sentiment 0.0
cnt
Japan
Importance 0.0 Sentiment 0.0
Relationships
Merck & Co. related ↔ China
China strategic rival ↔ Japan China views Japan as a major strategic rival, responding to Tokyo's alignment with the US and its stance on Taiwan by im
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.